BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

2604 related articles for article (PubMed ID: 23146133)

  • 1. Association between white matter hyperintensity severity and cognitive impairment according to the presence of the apolipoprotein E (APOE) ε4 allele in the elderly: retrospective analysis of data from the CREDOS study.
    Son SJ; Lee KS; Lee Y; Baek JH; Choi SH; Na DL; Seo SW; Oh BH; Hong CH
    J Clin Psychiatry; 2012 Dec; 73(12):1555-62. PubMed ID: 23146133
    [TBL] [Abstract][Full Text] [Related]  

  • 2.
    Mirza SS; Saeed U; Knight J; Ramirez J; Stuss DT; Keith J; Nestor SM; Yu D; Swardfager W; Rogaeva E; St George Hyslop P; Black SE; Masellis M;
    Neurology; 2019 Nov; 93(19):e1807-e1819. PubMed ID: 31575706
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apolipoprotein E genotype and the diagnostic accuracy of cerebrospinal fluid biomarkers for Alzheimer disease.
    Lautner R; Palmqvist S; Mattsson N; Andreasson U; Wallin A; Pålsson E; Jakobsson J; Herukka SK; Owenius R; Olsson B; Hampel H; Rujescu D; Ewers M; Landén M; Minthon L; Blennow K; Zetterberg H; Hansson O;
    JAMA Psychiatry; 2014 Oct; 71(10):1183-91. PubMed ID: 25162367
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Independent and Interactive Influences of the APOE Genotype and Beta-Amyloid Burden on Cognitive Function in Mild Cognitive Impairment.
    Seo EH; Kim SH; Park SH; Kang SH; Choo IH;
    J Korean Med Sci; 2016 Feb; 31(2):286-95. PubMed ID: 26839485
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cognitive impairment in Alzheimer's disease is modified by APOE genotype.
    van der Vlies AE; Pijnenburg YA; Koene T; Klein M; Kok A; Scheltens P; van der Flier WM
    Dement Geriatr Cogn Disord; 2007; 24(2):98-103. PubMed ID: 17596691
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of anemia and white matter hyperintensities (WMH) on cognitive impairment in patients with amnestic mild cognitive impairment (MCI).
    Son SJ; Lee KS; Na DL; Seo SW; Kim CH; Kim JH; Oh BH; Hong CH
    Arch Gerontol Geriatr; 2012; 55(2):251-6. PubMed ID: 22093914
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Value of Brain Structural Magnetic Resonance Imaging Combined with APOE--
    Zhao W; Yin C; Yu F; Wan L; Che S; Cui L
    Contrast Media Mol Imaging; 2022; 2022():8613024. PubMed ID: 35317127
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apolipoprotein E genotype and cerebrovascular alterations can influence conversion to dementia in patients with mild cognitive impairment.
    Viticchi G; Falsetti L; Vernieri F; Altamura C; Altavilla R; Luzzi S; Bartolini M; Provinciali L; Silvestrini M
    J Alzheimers Dis; 2014; 41(2):401-10. PubMed ID: 24625799
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inheritance of the ApoE epsilon4 allele increases the rate of brain atrophy in dementia patients.
    Wahlund LO; Julin P; Lannfelt L; Lindqvist J; Svensson L
    Dement Geriatr Cogn Disord; 1999; 10(4):262-8. PubMed ID: 10364643
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of Apolipoprotein E4 Polymorphism on the Gray Matter Volume and the White Matter Integrity in Subjective Memory Impairment without White Matter Hyperintensities: Voxel-Based Morphometry and Tract-Based Spatial Statistics Study under 3-Tesla MRI.
    Lee YM; Ha JK; Park JM; Lee BD; Moon E; Chung YI; Kim JH; Kim HJ; Mun CW; Kim TH; Kim YH
    J Neuroimaging; 2016; 26(1):144-9. PubMed ID: 25678236
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Double-blind crossover study of the cognitive effects of lorazepam in healthy apolipoprotein E (APOE)-epsilon4 carriers.
    Stonnington CM; Snyder PJ; Hentz JG; Reiman EM; Caselli RJ
    J Clin Psychiatry; 2009 Oct; 70(10):1379-84. PubMed ID: 19573495
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction of white matter hyperintensities (WMHs) and apolipoprotein E (APOE) genotypes on cognition in patients with amnestic mild cognitive impairment (aMCI).
    Yoon B; Shim YS; Cheong HK; Kim YD; Lee KO; Hong YJ; Oh YS; Na HR; Kim BC; Choi SH; Yang DW
    Arch Gerontol Geriatr; 2013; 57(3):292-7. PubMed ID: 23688406
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ASSOCIATION BETWEEN APOE-ε
    Mimenza-Alvarado AJ; Suing-Ortega MJ; Tusie-Luna T; Juárez-Cedillo T; Ávila-Funes JA; Aguilar-Navarro SG
    Rev Invest Clin; 2022; 74(2):113-120. PubMed ID: 35354197
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lack of reliable evidence for a distinctive ε4-related cognitive phenotype that is independent from clinical diagnostic status: findings from the Australian Imaging, Biomarkers and Lifestyle Study.
    Foster JK; Albrecht MA; Savage G; Lautenschlager NT; Ellis KA; Maruff P; Szoeke C; Taddei K; Martins R; Masters CL; Ames D;
    Brain; 2013 Jul; 136(Pt 7):2201-16. PubMed ID: 23737466
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apolipoprotein E epsilon4 allele, temporal lobe atrophy, and white matter lesions in late-life dementias.
    Barber R; Gholkar A; Scheltens P; Ballard C; McKeith IG; Morris CM; O'Brien JT
    Arch Neurol; 1999 Aug; 56(8):961-5. PubMed ID: 10448801
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cognitive domain decline in healthy apolipoprotein E epsilon4 homozygotes before the diagnosis of mild cognitive impairment.
    Caselli RJ; Reiman EM; Locke DE; Hutton ML; Hentz JG; Hoffman-Snyder C; Woodruff BK; Alexander GE; Osborne D
    Arch Neurol; 2007 Sep; 64(9):1306-11. PubMed ID: 17846270
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apolipoprotein epsilon4 and neuropsychological performance in Alzheimer's disease and vascular dementia.
    McGuinness B; Carson R; Barrett SL; Craig D; Passmore AP
    Neurosci Lett; 2010 Oct; 483(1):62-6. PubMed ID: 20678545
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association Between Apolipoprotein E ε2 vs ε4, Age, and β-Amyloid in Adults Without Cognitive Impairment.
    Insel PS; Hansson O; Mattsson-Carlgren N
    JAMA Neurol; 2021 Feb; 78(2):229-235. PubMed ID: 33044487
    [TBL] [Abstract][Full Text] [Related]  

  • 19. APOE ε4 allele status in korean dementia patients with severe white matter hyperintensities.
    Hong YJ; Yoon B; Shim YS; Cho AH; Shin HE; Kim YI; Kim SY; Yang DW
    J Alzheimers Dis; 2011; 24(3):519-24. PubMed ID: 21297273
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential effects of white matter hyperintensity on geriatric depressive symptoms according to APOE-ε4 status.
    Chang KJ; Hong CH; Lee KS; Roh HW; Choi SH; Kim SY; Na DL; Seo SW; Kim DK; Kang DR; Kim J; Lee Y; Kim SH; Back JH; Chung YK; Lim KY; Noh JS; Oh BH; Son SJ
    J Affect Disord; 2015 Dec; 188():28-34. PubMed ID: 26340080
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 131.